quinoxalines has been researched along with scopolamine hydrobromide in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 8 (47.06) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deschênes, M; Pinault, D | 1 |
Hahn, F; Mitze, R; Somorjai, K; Zahradnik, HP | 1 |
Bertolino, M; Costa, E; DiBella, M; Guidotti, A; Thompson, DM; Uzunov, D; Zivkovic, I | 1 |
Changeux, JP; Vidal, C | 1 |
Bernardi, G; Calabresi, P; Mercuri, NB | 1 |
Dragunow, M; Young, D | 2 |
McEwen, BS; Woolley, CS | 1 |
Bittigau, P; Bosch, F; Dikranian, K; Ikonomidou, C; Miksa, M; Olney, JW; Stefovska, V; Tenkova, TI; Turski, L; Vöckler, J | 1 |
Dikranian, K; Farber, NB; Heinkel, C; Jiang, XP; Kim, SH | 1 |
Chopin, P; Colpaert, FC; Marien, M | 1 |
Duvoisin, RM; Grandes, P; Kushmerick, C; Price, GD; Puente, N; Renden, R; Taschenberger, H; von Gersdorff, H; Wadiche, JI | 1 |
Del Arco, A; Mora, F; Segovia, G | 1 |
Aas, P; Enger, S; Myhrer, T | 1 |
Biała, G; Budzyńska, B; Kruk-Słomka, M | 1 |
Lenda, T; Pałucha-Poniewiera, A; Pilc, A; Podkowa, A; Podkowa, K; Sałat, K | 1 |
Anderson, WH; Catlow, JT; Felder, CC; Higgs, RE; Kuo, MS; Laksmanan, A; Li, X; Martin, AE; Nikolayev, A; Schober, DA; Tolstikov, VV; Witkin, JM | 1 |
17 other study(ies) available for quinoxalines and scopolamine hydrobromide
Article | Year |
---|---|
Control of 40-Hz firing of reticular thalamic cells by neurotransmitters.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Animals; Bicuculline; Electric Conductivity; Female; gamma-Aminobutyric Acid; Ketanserin; Kynurenic Acid; Male; Neurons; Neurotransmitter Agents; Prazosin; Quinoxalines; Rats; Rats, Sprague-Dawley; Reticular Formation; Scopolamine; Thalamic Nuclei | 1992 |
Effect of mepyramine and spasmolytic agents on guinea-pig anaphylaxis with special reference to the protracted shock.
Topics: Anaphylaxis; Animals; Antigens; Benzyl Compounds; Bromine; Dioxoles; Dose-Response Relationship, Drug; Ethylamines; Ethylenediamines; Female; Guinea Pigs; Histamine H1 Antagonists; Lactones; Male; Ovalbumin; Papaverine; Parasympatholytics; Pyridines; Quinoxalines; Scopolamine; Styrenes | 1972 |
7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
Topics: Alprazolam; Animals; Avoidance Learning; Benzothiadiazines; Brain; Chlorothiazide; Cognition; Diazoxide; Electrophysiology; Glutamates; Ligands; Male; Maze Learning; Phosphatidylinositols; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Muscarinic; Scopolamine; Stereoisomerism; Synaptosomes | 1995 |
Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Atropine; Bungarotoxins; Cerebral Cortex; Dimethylphenylpiperazinium Iodide; Electric Stimulation; Evoked Potentials; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Male; Mecamylamine; Membrane Potentials; Muscarine; Neurons; Nicotine; Pirenzepine; Pyramidal Tracts; Quinoxalines; Rats; Rats, Sprague-Dawley; Scopolamine; Synaptic Transmission; Tubocurarine | 1993 |
Chemical modulation of synaptic transmission in the striatum.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Baclofen; Bicuculline; Corpus Striatum; Dopamine; Electric Stimulation; Evoked Potentials; gamma-Aminobutyric Acid; In Vitro Techniques; Kynurenic Acid; Muscarine; Quinoxalines; Rats; Receptors, Dopamine D2; Receptors, GABA-B; Receptors, Muscarinic; Scopolamine; Synaptic Transmission | 1993 |
MK-801 and NBQX prevent electrically induced status epilepticus.
Topics: Animals; Atropine; Cerebral Ventricles; Dizocilpine Maleate; Electric Stimulation; Hippocampus; Injections, Intraperitoneal; Injections, Intraventricular; Male; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Scopolamine; Status Epilepticus | 1994 |
Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dendrites; Dizocilpine Maleate; Estradiol; Female; Hippocampus; Ovariectomy; Quinoxalines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |
Non-NMDA glutamate receptors are involved in the maintenance of status epilepticus.
Topics: Animals; Anticonvulsants; Atropine; Brain; Cerebral Ventricles; Dizocilpine Maleate; Electric Stimulation; Electroencephalography; Hippocampus; Injections, Intraventricular; Male; Quinoxalines; Rats; Rats, Wistar; Receptors, Glutamate; Receptors, Muscarinic; Scopolamine; Status Epilepticus | 1993 |
Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.
Topics: Animals; Apoptosis; Brain; Calcium Channel Blockers; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fetus; Haloperidol; Immunohistochemistry; In Situ Nick-End Labeling; Microscopy, Electron; Muscarinic Antagonists; Nerve Degeneration; Neurons; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1999 |
Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity.
Topics: Adrenergic alpha-Agonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carbachol; Carbazoles; Cerebral Cortex; Clonidine; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Kainic Acid; Models, Neurological; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Phenazocine; Prosencephalon; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Scopolamine | 2002 |
Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aging; Animals; Anti-Anxiety Agents; Avoidance Learning; Basal Nucleus of Meynert; Benzopyrans; Brimonidine Tartrate; Cholinesterase Inhibitors; Cognition; Diazepam; Excitatory Amino Acid Agonists; Ibotenic Acid; Imidazoles; Male; Maze Learning; Memory; Mice; Muscarinic Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Scopolamine; Tacrine | 2002 |
Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Amino Acids; Animals; Benzoxazines; Brain Stem; Calcium Signaling; Cannabinoid Receptor Modulators; Endocannabinoids; Evoked Potentials, Auditory, Brain Stem; Glycine; Ion Transport; Morpholines; Naphthalenes; Nerve Endings; Patch-Clamp Techniques; Picrotoxin; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Receptors, Presynaptic; Resorcinols; Scopolamine; Synaptic Transmission; Xanthenes | 2004 |
Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholinergic Antagonists; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Flupenthixol; Glutamic Acid; Homovanillic Acid; Injections, Intraventricular; Male; Mecamylamine; Microinjections; Motor Activity; Muscarinic Antagonists; N-Methylaspartate; Nicotinic Antagonists; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Scopolamine | 2008 |
Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Disease Models, Animal; Electroencephalography; GABA Agonists; Male; Muscarinic Antagonists; Muscimol; Procyclidine; Quinoxalines; Rats; Rats, Wistar; Scopolamine; Seizures; Soman; Statistics, Nonparametric | 2010 |
Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice.
Topics: Animals; Benzazepines; Male; Maze Learning; Mecamylamine; Memory; Mice; Motor Activity; Nicotine; Quinoxalines; Receptors, Cholinergic; Scopolamine; Varenicline | 2012 |
Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
Topics: Amino Acids; Animals; Antidepressive Agents; Depressive Disorder; Excitatory Amino Acid Antagonists; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Prefrontal Cortex; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Scopolamine; Serotonin; Xanthenes | 2016 |
Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.
Topics: Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Frontal Lobe; Ketamine; Male; Metabolome; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Quinoxalines; Receptor, Muscarinic M1; Receptors, AMPA; Scopolamine; Selective Serotonin Reuptake Inhibitors; TOR Serine-Threonine Kinases | 2017 |